Bank Of New York Mellon Corp Dare Bioscience, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.87 - $1.36 $19,963 - $31,207	22,947 New	22,947 $23.9 Million
Q4 2022 Feb 14, 2023	BUY	$0.82 - $12.6 $21,276 - $326,932	25,947 New	25,947 $21,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $12.48 $664 - $7,974	639 Added 2.52%	25,947 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.76 $2,604 - $4,876	2,771 Added 12.3%	25,308 $31,000
Q1 2022 May 11, 2022	BUY	$1.42 - $2.09 $32,002 - $47,102	22,537 New	22,537 $34,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.